A new method that can rapidly determine whether a virus is infectious or non-infectious could revolutionize the response to future pandemics, researchers report. A new method that can rapidly ...

As gene therapies continue to advance, the demand for scalable, reproducible, and efficient potency assays is rapidly increasing—especially for adeno-associated virus (AAV) vectors. Accurate ...

New Instrument Counts and Sizes Viruses and Their Aggregates in Liquid Suspension There are two main categories of viral vaccines—live (attenuated) and killed (inactivated) vaccines. A live attenuated ...

The use of viruses and viral vectors in gene therapy, cell therapy, vaccines and basic research requires precise infectious titer assessments, often hindered by tedious and lengthy infectivity assays.

A new method that can rapidly determine whether a virus is infectious or non-infectious could revolutionize the response to future pandemics. Dr. Samuel Jones from Birmingham's School of Chemistry led ...

In a recent study published in Nature Communications, researchers from the University of Chicago discovered that the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) uses a small but ...

In a recent study posted to the bioRxiv* preprint server, researchers in the United States assess the efficacy of the human surfactant protein A (SP-A) against severe acute respiratory syndrome ...